This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (67)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Longitudinal Study

Daniel B. Fishbein, MD; Jonathan E. Kaplan, MD; Thomas J. Spira, MD; Bess Miller, MD; Lawrence B. Schonberger, MD; Paul F. Pinsky, MPH; Jane P. Getchell, DrPH; Vaniambabi S. Kalyanaraman, PhD; James S. Braude, MD

JAMA. 1985;254(7):930-935.

Abstract
In January 1982, the Centers for Disease Control began a prospective study of unexplained generalized lymphadenopathy syndrome in 78 homosexual or bisexual men. As of Aug 1, 1984, the median durations of lymphadenopathy and enrollment were 29.5 months and 20 months, respectively. Antibodies to human T-cell lymphotropic virus type III/ lymphadenopathy-associated virus were present in 75 (96%) of the study patients. Five (6%) of the patients were diagnosed as having the acquired immunodeficiency syndrome five to 25 months after the onset of lymphadenopathy. At the time of their initial visit, these five patients had lower T-helper cell counts, hematocrits, lymphocyte counts, and pokeweed mitogen stimulation ratios and were more likely to report severe symptoms than patients who did not develop the acquired immunodeficiency syndrome. During 318 follow-up visits, except for the development of the acquired immunodeficiency syndrome in five patients, there has been little change in the initial laboratory and clinical measures of this cohort. Within the follow-up period of this study, the features of lymphadenopathy syndrome have been unremitting for the majority of patients.

(JAMA 1985;254:930-935)

Author Affiliations
From the Divisions of Viral Diseases (Drs Fishbein, Kaplan, Miller, Schonberger, Getchell, and Kalyanaraman) and Host Factors (Dr Spira), Center for Infectious Diseases, Centers for Disease Control, Atlanta.

Footnotes
Reprint requests to Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA 30333 (Dr Fishbein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reasons for Decrease in Sexual Activity Among Homosexual Men With HIV Infection
Kaplan et al.
JAMA 1988;260:2836-2837.
ABSTRACT  

A Six-Year Follow-up of HIV-Infected Homosexual Men With Lymphadenopathy: Evidence for an Increased Risk for Developing AIDS After the Third Year of Lymphadenopathy
Kaplan et al.
JAMA 1988;260:2694-2697.
ABSTRACT  

Lymph Node Biopsy in Patients With Human Immunodeficiency Virus Infections
Davis et al.
Arch Surg 1988;123:1349-1352.
ABSTRACT  

Physician Use of the HIV Antibody Test: The Need for Consent, Counseling, Confidentiality, and Caution
Sherer
JAMA 1988;259:264-265.
ABSTRACT  

Infection with the Human Immunodeficiency Virus: Clinical Manifestations and Their Relationship to Immune Deficiency: A Report from the Multicenter AIDS Cohort Study
KASLOW et al.
ANN INTERN MED 1987;107:474-480.
ABSTRACT  

Antibody Responses After Influenza and Pneumococcal Immunization in HIV-Infected Homosexual Men
Huang et al.
JAMA 1987;257:2047-2050.
ABSTRACT  

Lymphadenopathy Syndrome in Homosexual Men: Evidence for Continuing Risk of Developing the Acquired Immunodeficiency Syndrome
Kaplan et al.
JAMA 1987;257:335-337.
ABSTRACT  

Surveillance for AIDS in a Central African City: Kinshasa, Zaire
Mann et al.
JAMA 1986;255:3255-3259.
ABSTRACT